Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Oct 20.
doi: 10.1038/s44318-025-00581-3. Online ahead of print.

Reticulophagy receptor FAM134C restrains BMP receptor signaling

Affiliations
Free article

Reticulophagy receptor FAM134C restrains BMP receptor signaling

Shuchen Gu et al. EMBO J. .
Free article

Abstract

FAM134/RETREG family members are ER-phagy receptors that maintain cellular homeostasis by regulating endoplasmic reticulum turnover. However, possible non-ER-phagy functions of FAM134 proteins remain elusive. Here, we show that RETREG3/FAM134C functions as a selective autophagy receptor for the type I BMP receptor (BMPRIA/ALK3) and recruits BMPRIA into LC3-containing autophagosomes for subsequent degradation. FAM134C-induced degradation diminishes the availability of BMP receptors and thus the strength of BMP signaling. Inhibition of autophagy through chemical means or knockdown of key autophagy regulators, ATG5 or Beclin-1, prevents BMPR1A degradation. Additionally, disruption of the putative LC3-interacting region (LIR) motif in FAM134C completely abolishes its interaction with LC3, thereby impeding its ability to degrade BMPR1A. Moreover, FAM134C-deficient mice exhibit enhanced BMP responses in the intestines, which affects intestinal crypt regeneration. Our findings suggest that FAM134C acts as a specific receptor that controls BMP signaling through the autophagic degradation of the type I BMP receptor, independent of its canonical role in ER-phagy.

Keywords: Autophagy; Degradation; RETREG; Smad; TGF-β.

PubMed Disclaimer

Conflict of interest statement

Disclosure and competing interests statement. The authors declare no competing interests.

References

    1. Akiyama T, Raftery LA, Wharton KA (2024) Bone morphogenetic protein signaling: the pathway and its regulation. Genetics 226:iyad200 - PubMed - DOI
    1. Bach SP, Renehan AG, Potten CS (2000) Stem cells: the intestinal stem cell as a paradigm. Carcinogenesis 21:469–476 - PubMed - DOI
    1. Bai S, Cao X (2002) A nuclear antagonistic mechanism of inhibitory Smads in transforming growth factor-beta signaling. J Biol Chem 277:4176–4182 - PubMed - DOI
    1. Bier E, De Robertis EM (2015) EMBRYO DEVELOPMENT. BMP gradients: a paradigm for morphogen-mediated developmental patterning. Science 348:aaa5838 - PubMed - DOI
    1. Blanpain C, Mohrin M, Sotiropoulou PA, Passegué E (2011) DNA-damage response in tissue-specific and cancer stem cells. Cell Stem Cell 8:16–29 - PubMed - DOI

LinkOut - more resources